Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • Bitcoin USD

    64,238.45
    +765.93 (+1.21%)
     
  • CMC Crypto 200

    1,382.50
    +69.88 (+5.32%)
     
  • S&P 500

    4,964.04
    -47.08 (-0.94%)
     
  • Dow

    37,979.60
    +204.22 (+0.54%)
     
  • Nasdaq

    15,266.08
    -335.42 (-2.15%)
     
  • Gold

    2,406.60
    +8.60 (+0.36%)
     
  • Crude Oil

    83.27
    +0.54 (+0.65%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

This Cathie Wood Stock Could Nearly Double, According to Wall Street

This Cathie Wood Stock Could Nearly Double, According to Wall Street

One stock that could ride the market rally is CRISPR Therapeutics (NASDAQ: CRSP). This biotech is seeking to develop breakthrough therapies for difficult-to-treat illnesses using gene editing, and the company's focus in this area earned it a prominent place in the Ark Genomic Revolution ETF, an exchange-traded fund overseen by Cathie Wood. Wood isn't the only one on Wall Street who likes CRISPR.